Form 4 for LONA LeonaBio, Inc.
Accepted 2022-10-31 00:00:00 ET · period of report 2022-10-28 · accession 0001209191-22-054950 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-10-31 | 2022-10-28 | LONA | CHURCH KEVIN | Executive VP, Research | M - OptEx | $1.35 | +3,700 | 61.4K | +6% | +$4,995 |
| D | 2022-10-31 | 2022-10-28 | LONA | CHURCH KEVIN | Executive VP, Research | M - OptEx | $0.00 | -3,700 | 6,410 | -37% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-28 | M | A | 3,700 | $1.35 | 61,395 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-10-28 | M | D | 3,700 | $0.00 | 6,410 | D | $1.35 · — to 2028-12-17 | 3,700 Common Stock | (F1) One-fourth of the shares subject to the option vested on January 1, 2020 and one-fourth of the shares subject to the option vest on each year thereafter. |